Armistice Capital, Llc Cassava Sciences Inc (SAVA) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of CASSAVA SCIENCES INC. Currently has a direct ownership of 1.65 Million shares of SAVA, which is worth approximately $42.9 Million. The most recent transaction as insider was on Oct 03, 2018, when has been sold 512,660 shares (Common Stock) at a price of $1.31 per share, resulting in proceeds of $671,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M

0% 3M change

0% 12M change

Total Value Held $42.9 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2018	SELL Open market or private sale	$671,585 $1.31 p/Share	512,660 Reduced 23.69%	1,651,340 Common Stock
Aug 20 2018	SELL Open market or private sale	$7,280 $0.91 p/Share	8,000 Reduced 0.37%	2,164,000 Common Stock
Aug 17 2018	SELL Open market or private sale	$45,600 $0.95 p/Share	48,000 Reduced 2.16%	2,172,000 Common Stock
Aug 16 2018	SELL Open market or private sale	$1,224,000 $1.02 p/Share	1,200,000 Reduced 35.09%	2,220,000 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL